ACADIA Pharmaceuticals Inc
SWB:DR6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ACADIA Pharmaceuticals Inc
SWB:DR6
|
US |
|
E
|
Experian PLC
OTC:EXPGF
|
IE |
|
D
|
Deutsche Bank AG
F:DBK
|
DE |
Wall St Price Targets
DR6 Price Targets Summary
ACADIA Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for DR6 is 27.84 EUR with a low forecast of 14.85 EUR and a high forecast of 40.87 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DR6's stock price target?
Price Target
27.84
EUR
According to Wall Street analysts, the average 1-year price target for DR6 is 27.84 EUR with a low forecast of 14.85 EUR and a high forecast of 40.87 EUR.
What is the Revenue forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
14%
The compound annual growth rate for Revenue over the next 3 years is 14%.
What is the Gross Profit forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
15%
The compound annual growth rate for Gross Profit over the next 3 years is 15%.
What is the Operating Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
37%
The compound annual growth rate for Operating Income over the next 3 years is 37%.
What is the Pre-Tax Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
33%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 33%.
What is the Net Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
-10%
The compound annual growth rate for Net Income over the next 3 years is -10%.
